These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25323905)

  • 1. DNA hypomethylation-mediated overexpression of carbonic anhydrase 9 induces an aggressive phenotype in ovarian cancer cells.
    Sung HY; Ju W; Ahn JH
    Yonsei Med J; 2014 Nov; 55(6):1656-63. PubMed ID: 25323905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant hypomethylation-mediated AGR2 overexpression induces an aggressive phenotype in ovarian cancer cells.
    Sung HY; Choi EN; Lyu D; Park AK; Ju W; Ahn JH
    Oncol Rep; 2014 Aug; 32(2):815-20. PubMed ID: 24920423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of mucin 13 due to promoter methylation promotes aggressive behavior in ovarian cancer cells.
    Sung HY; Park AK; Ju W; Ahn JH
    Yonsei Med J; 2014 Sep; 55(5):1206-13. PubMed ID: 25048476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synaptotagmin-like protein 2 gene promotes the metastatic potential in ovarian cancer.
    Sung HY; Han J; Ju W; Ahn JH
    Oncol Rep; 2016 Jul; 36(1):535-41. PubMed ID: 27220283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant DNA methylation in the IFITM1 promoter enhances the metastatic phenotype in an intraperitoneal xenograft model of human ovarian cancer.
    Kim NH; Sung HY; Choi EN; Lyu D; Choi HJ; Ju W; Ahn JH
    Oncol Rep; 2014 May; 31(5):2139-46. PubMed ID: 24676393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer.
    Zhang W; Barger CJ; Link PA; Mhawech-Fauceglia P; Miller A; Akers SN; Odunsi K; Karpf AR
    Epigenetics; 2015; 10(8):736-48. PubMed ID: 26098711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant epigenetic regulation of GABRP associates with aggressive phenotype of ovarian cancer.
    Sung HY; Yang SD; Ju W; Ahn JH
    Exp Mol Med; 2017 May; 49(5):e335. PubMed ID: 28524180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant Hypomethylation of Solute Carrier Family 6 Member 12 Promoter Induces Metastasis of Ovarian Cancer.
    Sung HY; Yang SD; Park AK; Ju W; Ahn JH
    Yonsei Med J; 2017 Jan; 58(1):27-34. PubMed ID: 27873492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
    Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
    Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter hypermethylation influences the suppressive role of maternally expressed 3, a long non-coding RNA, in the development of epithelial ovarian cancer.
    Sheng X; Li J; Yang L; Chen Z; Zhao Q; Tan L; Zhou Y; Li J
    Oncol Rep; 2014 Jul; 32(1):277-85. PubMed ID: 24859196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation of the CA9 promoter can modulate expression of the tumor-associated carbonic anhydrase IX in dense carcinoma cell lines.
    Jakubicková L; Biesová Z; Pastoreková S; Kettmann R; Pastorek J
    Int J Oncol; 2005 Apr; 26(4):1121-7. PubMed ID: 15754010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmembrane protein 88 (TMEM88) promoter hypomethylation is associated with platinum resistance in ovarian cancer.
    de Leon M; Cardenas H; Vieth E; Emerson R; Segar M; Liu Y; Nephew K; Matei D
    Gynecol Oncol; 2016 Sep; 142(3):539-47. PubMed ID: 27374141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant methylation of RASSF2A in tumors and plasma of patients with epithelial ovarian cancer.
    Wu Y; Zhang X; Lin L; Ma XP; Ma YC; Liu PS
    Asian Pac J Cancer Prev; 2014; 15(3):1171-6. PubMed ID: 24606436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
    Mossman D; Kim KT; Scott RJ
    BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [E-cadherin promoter methylation and demethylation in epithelial ovarian carcinoma cells].
    Qu PP; Shi Z; Li N
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):538-41. PubMed ID: 19957556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide methylation profiling of ovarian cancer patient-derived xenografts treated with the demethylating agent decitabine identifies novel epigenetically regulated genes and pathways.
    Tomar T; de Jong S; Alkema NG; Hoekman RL; Meersma GJ; Klip HG; van der Zee AG; Wisman GB
    Genome Med; 2016 Oct; 8(1):107. PubMed ID: 27765068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic silencing of DKK2 and Wnt signal pathway components in human ovarian carcinoma.
    Zhu J; Zhang S; Gu L; Di W
    Carcinogenesis; 2012 Dec; 33(12):2334-43. PubMed ID: 22964660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant promoter methylation and expression of UTF1 during cervical carcinogenesis.
    Guenin S; Mouallif M; Deplus R; Lampe X; Krusy N; Calonne E; Delbecque K; Kridelka F; Fuks F; Ennaji MM; Delvenne P
    PLoS One; 2012; 7(8):e42704. PubMed ID: 22880087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis.
    Loginov VI; Pronina IV; Burdennyy AM; Filippova EA; Kazubskaya TP; Kushlinsky DN; Utkin DO; Khodyrev DS; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2018 Jul; 662():28-36. PubMed ID: 29631007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulatory action of the DNA methyltransferase inhibitor SGI-110 in epithelial ovarian cancer cells and xenografts.
    Srivastava P; Paluch BE; Matsuzaki J; James SR; Collamat-Lai G; Taverna P; Karpf AR; Griffiths EA
    Epigenetics; 2015; 10(3):237-46. PubMed ID: 25793777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.